BioSpace News Archive

Combination of prodrug and a prodrug-activating biomaterial improve the therapeutic index and responses to conventional chemotherapy

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, announced its participation at two upcoming conferences in November

Achieved Third Quarter 2019 ONPATTRO® Global Net Product Revenues of $46.1 Million, Including Initial Sales in Japan, with Over 600 Patients on Commercial Product Worldwide

Hemostemix Inc. is a biotechnology company developing and commercializing blood-derived stem cell therapies for unmet medical conditions, announces that it has conducted a comprehensive assessment of the status, timeline and financial requirements for the Company to complete its current ACP-01 Phase II clinical study for critical limb ischemia (“CLI”).

Profound Medical Corp., the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced that management will participate in two investor conferences in November.

ANI Pharmaceuticals, Inc. announced that its partner Pharmaceutics International Inc. has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection, USP 500mg/10ml ANI plans to launch this currently unavailable drug in December, introducing this critical drug for the treatment of ventricular fibrillation and life-threatening ventricular arrhythmias, such as ventricular tachycardia.

Cryoport, Inc., the world’s leading temperature-controlled logistics company dedicated to the life sciences industry, announced that the Company will report financial results for the third quarter ended September 30, 2019 on Thursday, November 7, 2019 after U.S. markets close.

Galmed Pharmaceuticals Ltd. announced that it will present new data at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases in Boston, November 8-12, 2019.

Arena Pharmaceuticals, Inc. will release its third quarter 2019 financial results and provide a corporate update on Thursday, November 7, 2019, after the close of the U.S. financial markets.

Written by Thomas J. Kleeman, M.D., Release Yourself from Back Pain Without Opioids is based on 30 years of research and details seven drug-free techniques for treating low back pain